Home  |  Contact

Cellosaurus HuO9 (CVCL_1298)

[Text version]

Cell line name HuO9
Synonyms Huo9; HUO9; Hu09
Accession CVCL_1298
Resource Identification Initiative To cite this cell line use: HuO9 (RRID:CVCL_1298)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: COSMIC cell lines project.
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: Transcriptome analysis.
Sequence variations Has no TP53 mutation (PubMed=9359923).
Disease Osteosarcoma (NCIt: C9145)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_R725 (HuO9-M112)CVCL_R726 (HuO9-M132)CVCL_JG37 (HuO9/CMV-Luc)
Originate from same individual CVCL_2958 ! HuO9N2
Sex of cell Female
Age at sampling 13Y
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; JCRB

Markers:
AmelogeninX
CSF1PO10,11
D5S81813
D7S82010
D13S31711
D16S53911
TH019
TPOX9
vWA14

Run an STR similarity search on this cell line
Publications

PubMed=2691514; DOI=10.1007/BF00391353
Kawai A., Ozaki T., Ikeda S., Oda T., Miyazaki M., Sato J., Taketa K., Inoue H.
Two distinct cell lines derived from a human osteosarcoma.
J. Cancer Res. Clin. Oncol. 115:531-536(1989)

DOI=10.11418/jtca1981.16.3_173
Mihara K., Miyazaki M., Fushimi K., Tsuji T., Inoue Y., Fukaya K.-I., Ohashi R., Namba M.
The p53 gene status and other cellular characteristics of human cell lines maintained in our laboratory.
Tissue Cult. Res. Commun. 16:173-178(1997)

PubMed=9359923; DOI=10.18926/AMO/30789
Mihara K., Miyazaki M., Kondo T., Fushimi K., Tsuji T., Inoue Y., Fukaya K.-I., Ishioka C., Namba M.
Yeast functional assay of the p53 gene status in human cell lines maintained in our laboratory.
Acta Med. Okayama 51:261-265(1997)

PubMed=26351324; DOI=10.1158/1535-7163.MCT-15-0074
Teicher B.A., Polley E.C., Kunkel M., Evans D., Silvers T.E., Delosh R.M., Laudeman J., Ogle C., Reinhart R., Selby M., Connelly J., Harris E., Monks A., Morris J.
Sarcoma cell line screen of oncology drugs and investigational agents identifies patterns associated with gene and microRNA expression.
Mol. Cancer Ther. 14:2452-2462(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections JCRB; JCRB0427
Cell line databases/resources CCLE; HUO9_BONE
Cell_Model_Passport; SIDM00599
Cosmic-CLP; 907072
GDSC; 907072
LINCS_LDP; LCL-1423
Biological sample resources BioSample; SAMN03471626
Chemistry resources ChEMBL-Cells; CHEMBL3308748
ChEMBL-Targets; CHEMBL1075476
Gene expression databases ArrayExpress; E-MTAB-3610
GEO; GSM320823
GEO; GSM1669921
GEO; GSM1676303
GEO; GSM1701638
Other Wikidata; Q54896887
Polymorphism and mutation databases Cosmic; 907072
Cosmic; 931040
IARC_TP53; 21390